RHOADS ANN D
SEC Form 4 insider trading activity
RHOADS ANN D has filed 7 SEC Form 4 filings (9 transaction rows) across 3 companies, including GMED, QDEL, RPTX, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Jun 8, 2026.
On the most recent filing, RHOADS ANN D is listed as Director at QuidelOrtho Corp. Inside the rolling window, RHOADS ANN D reported 1 open-market purchase totaling $21K in QDEL and 3 open-market sales totaling $1.4M in GMED. The largest disclosed transaction in the window is a sale of 8,000 GMED shares on Nov 7, 2025, worth $648K.
Companies traded
Other insiders at GMED
Insider Buying
$21K
reported purchases (SEC code P)
Insider Selling
$1.4M
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has RHOADS ANN D made?
RHOADS ANN D has filed 7 SEC Form 4 filings (9 transaction rows) across 3 companies, including GMED, QDEL, RPTX since 2025.
Which companies does RHOADS ANN D trade?
RHOADS ANN D has filed SEC Form 4 disclosures for 3 companies, including GMED, QDEL, RPTX.
When was RHOADS ANN D's most recent SEC Form 4 filing?
RHOADS ANN D's most recent SEC Form 4 filing on Tracefour is dated Jun 8, 2026.
What is RHOADS ANN D's total buy and sell value in the current window?
Inside the rolling retention window, RHOADS ANN D bought $21K and sold $1.4M based on SEC Form 4 filings.
What was RHOADS ANN D's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 8,000 GMED shares on 2025-11-07, worth $648K, per SEC Form 4 filings.